International guidelines agree on the management of patients with grade 1 and 2 ChILI, with recommendations being to maintain ICIs for grade 1 hepatitis and temporarily discontinue ICIs until ALT normalisation or improvement for grade 1 hepatitis.17 This evidence concerns the gene GPT and hepatitis A virus infection.